![VBI Vaccines](https://microsmallcap.com/wp-content/uploads/2017/10/VBI-Vaccines-Inc-and-Its-Technical-Indicators-374x295.jpg)
Biotechnology
VBI Vaccines Inc and Its Technical Indicators
VBI Vaccines Inc (NASDAQ:$VBIV) may have caught the attention of investors when the SuperTrend line crossed above the current stock price recently. This indicator may signal that the stock may soon enter ‘Buy’ territory. The ... [Read]
![VBI Vaccines, Inc.](https://microsmallcap.com/wp-content/uploads/2017/10/VBI-Vaccines-Inc-What-Can-We-Learn-From-Indicators-and-Metrics-374x295.jpg)
Biotechnology
VBI Vaccines, Inc.: What Can We Learn From Indicators and Metrics?
VBI Vaccines (NASDAQ:$VBIV) is a healthcare company specializing in the biotechnology industry. They have seen relatively little movement over the past month. So what can the technical indicators tell us about this pharmaceutical company? Let’s ... [Read]
![Spectrum Pharmaceuticals VS PTC Therapeutics](https://microsmallcap.com/wp-content/uploads/2017/10/Head-to-Head-Spectrum-Pharmaceuticals-VS-PTC-Therapeutics-374x295.jpg)
Biotechnology
Head-to-Head: Spectrum Pharmaceuticals VS PTC Therapeutics
Two healthcare companies hitting new highs recently are Spectrum Pharmaceuticals (NASDAQ:$SPPI) and PTC Therapeutics (NASDAQ:$PTCT). However, where do you start when weighing them against each other? Let’s look at the stats. Spectrum Pharmaceuticals is a ... [Read]
Biotechnology
Versartis Shares Plunged a Whopping 82% Today
Versartis Inc. (NASDAQ:$VSAR) shares plunged a whopping 82% late Thursday. Why? It all started after the California-based biopharmaceutical company announced that its drug Somavaratan failed to meet its endpoint in a phase 3 trial. The ... [Read]
Biotechnology
Intercept Pharmaceuticals Plunged Today, Here’s Why
On Thursday, September 21, as of 3:26 p.m. EDT, Intercept Pharmaceuticals (NASDAQ:$ICPT) plunged 21%. What happened? Well, the fall began after the FDA released a safety announcement warning the public that when Intercept’s liver disease ... [Read]
![Iovance Biotherapeutics, Inc.](https://microsmallcap.com/wp-content/uploads/2017/10/Iovance-Biotherapeutics-Inc-Sets-Prices-for-50-Million-Common-Stock-Offering-374x295.jpg)
Biotechnology
Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering
Iovance Biotherapeutics, Inc (NASDAQ:$IOVA) has announced pricing for their $50 million common stock offering. The company will offer 7,692,308 shares of its common stock at the price of $6.50 per share. Gross profits from this ... [Read]
![VBI Vaccines, Inc.](https://microsmallcap.com/wp-content/uploads/2017/10/Zacks-Investment-Research-Upgrades-VBI-Vaccines-Rating-374x295.jpg)
Biotechnology
Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating
In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]
![VBI Vaccines](https://microsmallcap.com/wp-content/uploads/2017/10/VBI-Vaccines-Rating-Upgraded-by-Zacks-Investment-Research-374x295.jpg)
Biotechnology
VBI Vaccines’ Rating Upgraded by Zacks Investment Research
VBI Vaccines Inc (NASDAQ:$VBIV) saw its stock rating with Zacks Investment Research rise from ‘Sell’ to ‘Hold’ in a research note from Tuesday. VBIV is a biopharmaceuticals company that develops new technology focused on expanding ... [Read]
![Best Time to Buy Iovance Biotherapeutics](https://microsmallcap.com/wp-content/uploads/2017/10/This-is-Why-Right-Now-is-the-Best-Time-to-Buy-Iovance-Biotherapeutics-374x295.jpg)
Biotechnology
This is Why Right Now is the Best Time to Buy Iovance Biotherapeutics
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) is a huge mover this week as shares have increased 5.10%, or $0.4 during the last trading session. In total, about 568,977 shares have been traded, 39.85% up from the average. ... [Read]
Biotechnology
Nabriva Therapeutics Stock Increased Today, Here’s Why
If you’re looking to get into biotech investing, you might want to think about adding Nabriva Therapeutics (NASDAQ:$NBRV) to your investment portfolio. For the second day in a row, the company is witnessing double-digit gains. ... [Read]